Literature DB >> 60330

Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen.

G Schmidt, H Mayer, P H Mäkelä.   

Abstract

In Salmonella, ilv-linked rfe genes participate in the biosynthesis of the enterobacterial common antigen (CA) as well as of certain types of O antigen (serogroups C1 and L). rff genes, probably in the same cluster with rfe, are required for CA synthesis (P.H. Mäkelä et al., in preparation). Several Escherichia coli strains were studied to determine whether they also have rfe-rff genes that are involved in the synthesis of O antigen and CA, or of CA only. In a first approach, E, coli K-12 F-prime factors carrying the genes ilv and argH or argE and presumably rfe-rff genes were introduced into CA-negative Salmonella mutants that are blocked in CA synthesis because of mutated rfe or rff genes. All resulting ilv+ hybrids were CA positive. In recipients with group C1-derived rfb genes, the synthesis of O6,7-specific antigen was also restored. This result shows that E. coli K-12 has rfe and rff genes providing the functions required in the synthesis of CA and Salmonella 6,7-specific polysaccharide. By introduction of defective rfe regions from suitable Salmonella donors into E. coli O8, 09, and O100 strains, the synthesis of CA as well as of the O-specific polysaccharides was blocked. This indicates that in the E. coli strains tested the rfe genes are involved in the synthesis of both O antigen and CA. This suggestion was confirmed by the finding of E. coli rough mutants that had simultaneously become CA negative. In transduction experiments it could be shown that the appearance of the rough and CA- phenotype was due to a defect in the ilv-linked rfe region.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60330      PMCID: PMC232981          DOI: 10.1128/jb.127.2.755-762.1976

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

Review 1.  Linkage map of Salmonella typhimurium, edition IV.

Authors:  K E Sanderson
Journal:  Bacteriol Rev       Date:  1972-12

Review 2.  Escherichia coli K-12 F-prime factors, old and new.

Authors:  K B Low
Journal:  Bacteriol Rev       Date:  1972-12

Review 3.  F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony.

Authors:  K E Sanderson; H Ross; L Ziegler; P H Mäkelä
Journal:  Bacteriol Rev       Date:  1972-12

Review 4.  Linkage map of Escherichia coli strain K-12.

Authors:  A L Taylor; C D Trotter
Journal:  Bacteriol Rev       Date:  1972-12

5.  Genetical studies on the lipopolysaccharide structure of Escherichia coli K12.

Authors:  G Schmidt
Journal:  J Gen Microbiol       Date:  1973-07

Review 6.  Bacteriophage receptors.

Authors:  A A Lindberg
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

7.  Immunochemistry of R lipopolysaccharides of Escherichia coli. Different core regions in the lipopolysaccharides of O group 8.

Authors:  G Schmidt; B Jann; K Jann
Journal:  Eur J Biochem       Date:  1969-10

8.  Glyceraldehyde phosphate at the reducing terminus of Salmonella Q haptens. Salmonella montevideo.

Authors:  J Gmeiner
Journal:  Eur J Biochem       Date:  1975-02-21

9.  Escherichia coli capsule bacteriophages. II. Morphology.

Authors:  S Stirm; E Freund-Mölbert
Journal:  J Virol       Date:  1971-09       Impact factor: 5.103

10.  Participation of lipopolysaccharide genes in the determination of the entobacterial common antigen: analysis in Salmonella groups B and C1.

Authors:  P H Mäkelä
Journal:  J Bacteriol       Date:  1974-09       Impact factor: 3.490

View more
  19 in total

1.  The N-terminal region of the Escherichia coli WecA (Rfe) protein, containing three predicted transmembrane helices, is required for function but not for membrane insertion.

Authors:  A O Amer; M A Valvano
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

2.  Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems.

Authors:  Michael Wacker; Mario F Feldman; Nico Callewaert; Michael Kowarik; Bradley R Clarke; Nicola L Pohl; Marcela Hernandez; Enrique D Vines; Miguel A Valvano; Chris Whitfield; Markus Aebi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

Review 3.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

4.  Genetic location of genes encoding enterobacterial common antigen.

Authors:  U Meier; H Mayer
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

Review 5.  Linkage map of Escherichia coli K-12, edition 6.

Authors:  B J Bachmann; K B Low
Journal:  Microbiol Rev       Date:  1980-03

6.  Enterobacterial common antigen in mutant strains of Salmonella.

Authors:  D Männel; P H Mäkelä; H Mayer
Journal:  J Bacteriol       Date:  1978-08       Impact factor: 3.490

7.  Characterization of an Escherichia coli rff mutant defective in transfer of N-acetylmannosaminuronic acid (ManNAcA) from UDP-ManNAcA to a lipid-linked intermediate involved in enterobacterial common antigen synthesis.

Authors:  K Barr; S Ward; U Meier-Dieter; H Mayer; P D Rick
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

8.  Demonstration of enterobacterial common antigen by bacterial agglutination.

Authors:  A Marx; M Petcovici; N Nacescu; H Mayer; G Schmidt
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Expression of the cloned Escherichia coli O9 rfb gene in various mutant strains of Salmonella typhimurium.

Authors:  T Sugiyama; N Kido; T Komatsu; M Ohta; N Kato
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

10.  Localization of enterobacterial common antigen:immunogenic and nonimmunogenic enterobacterial common antigen-containing Escherichia coli.

Authors:  J Rinno; J R Golecki; H Mayer
Journal:  J Bacteriol       Date:  1980-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.